A sensitivity analysis was conducted to analyze the effect of a +/- 30% variation in both drug costs and pharmacist salary (Table 2 ). In the worst-case scenario where there is a combination of a 30% decrease in drug cost and a 30% increase in the pharmacist’s salary, there is still a net savings of $79.5K CAD/year. There would have to be a 63% reduction in drug costs or a 173% increase in pharmacist salary for the cost-effectiveness of adding a pharmacist as part of the transfusion medicine team to be lost. These drastic changes in drug cost and pharmacist salaries are highly unlikely; therefore, the strategy of adding a pharmacist to manage coagulation factors remains beneficial.